Hims & Hers Health Stock Falls as Amazon Launches Competing Weight Loss Program
Hims & Hers Health (HIMS) stock dropped 4.03% following Amazon's announcement of a competing GLP-1 weight-loss program. The broader market also saw declines, with the S&P 500 and Nasdaq Composite falling 0.6% and 0.59%, respectively. The news highlights increased competition in the telehealth and weight-loss drug sectors.
Tickers: $AMWL $AMZN $HIMS $NVO $TDOC
Topics: competitor action FDA policy market sentiment stock price movement telehealth